Avalon GloboCare (ALBT) had the highest return between September 1, 2017 and April 30, 2018 by a US stock, returning 1,710,426.3%.
| ASSET | DATE | % RETURN |
|---|---|---|
Avalon GloboCare (ALBT) | 9/1/2017 - 4/30/2018 | 1,710,426.32% |
Freedom (FRHC) | 9/1/2017 - 4/30/2018 | 7,828.39% |
GT Biopharma (GTBP) | 9/1/2017 - 4/30/2018 | 4,866.38% |
SurgePays (SURG) | 9/1/2017 - 4/30/2018 | 4,723.53% |
Delcath Systems (DCTH) | 9/1/2017 - 4/30/2018 | 4,384.68% |
Quantum Computing (QUBT) | 9/1/2017 - 4/30/2018 | 2,700% |
TONX (TONX) | 9/1/2017 - 4/30/2018 | 1,300% |
Gyre Therapeutics (GYRE) | 9/1/2017 - 4/30/2018 | 760.69% |
Thryv (THRY) | 9/1/2017 - 4/30/2018 | 649.46% |
CASI Pharmaceuticals (CASI) | 9/1/2017 - 4/30/2018 | 593.75% |
Madrigal Pharmaceuticals (MDGL) | 9/1/2017 - 4/30/2018 | 566.75% |
Anixa Biosciences (ANIX) | 9/1/2017 - 4/30/2018 | 448.53% |
eGain (EGAN) | 9/1/2017 - 4/30/2018 | 394.29% |
Avalo Therapeutics (AVTX) | 9/1/2017 - 4/30/2018 | 389.47% |
Enphase Energy (ENPH) | 9/1/2017 - 4/30/2018 | 356.04% |
Lexaria Bioscience (LEXX) | 9/1/2017 - 4/30/2018 | 348.7% |
argenx NV ADR (ARGX) | 9/1/2017 - 4/30/2018 | 324.1% |
eXp World (EXPI) | 9/1/2017 - 4/30/2018 | 314.86% |
Rocket Pharmaceuticals (RCKT) | 9/1/2017 - 4/30/2018 | 314.42% |
BlueLinx (BXC) | 9/1/2017 - 4/30/2018 | 309.99% |
Gravity (GRVY) | 9/1/2017 - 4/30/2018 | 306.37% |
PetVivo (PETV) | 9/1/2017 - 4/30/2018 | 303.07% |
OLB (OLB) | 9/1/2017 - 4/30/2018 | 300% |
Empire Petroleum (EP) | 9/1/2017 - 4/30/2018 | 300% |
Nektar Therapeutics (NKTR) | 9/1/2017 - 4/30/2018 | 295.93% |
